News Detail
Related News
News Detail

RAZI INSTITUTE'S STRATEGIC VISION FOR THE NEXT CENTURY: EXPORTING PRODUCTS AND SHARING TECHNOLOGY EXPERTISE

en-news,inner news,branches,Media reflections,Announcements,conferences,workshops,exhibitions,Seminars,Multimedia
Publish Date : 17:00 - 2024/4/29
: Reading Time
Dr. Ali Es-haghi, Director General of Razi Vaccine and Serum Research Institute, highlighted the institute's focus on product export and technology transfer, particularly to African nations, at the Second International Economic Conference of Iran-Africa.

Reflecting on Razi Institute's upcoming 100th anniversary, Dr. Es-haghi emphasized the institute's century-long expertise in researching and manufacturing biological products. He underlined the potential for exporting Razi products as final product or bulk for packaging and distribution in other countries. Razi Institute is renowned for producing essential vaccines like MMR, DTP, and OPV, as well as life-saving anti-serums for snake and scorpion bites. These high-quality products have been instrumental in preventing fatalities in countries such as Afghanistan, Iraq, and various Persian Gulf countries.

Dr. Es-haghi also highlighted Razi Institute's advanced facilities, including 15 specialized laboratories and national and international reference labs. Notably, the WOAH Sheep and Goat Pox reference lab at Razi Institute, positioning it as a leading global facility in its field.

Dr. Es-haghi mentioned B2B exchange visits with economic stakeholders in Kenya and other East African countries during the seventh Joint Economic Commission meeting in Nairobi, Kenya, aiming to showcase Razi Institute's manufacturing capabilities and technology transfer in the African region.

Dr. Alireza Yousefi and Dr. Rainak Ghaderi from Razi Institute also attended this panel of Economic Conference of Iran-Africa.

New Comment :
Name: Email: Comment: